Table 4.

Consumption of recombinant human factor VIIa for patients with hemophilia, total doses, and number of vials associated with cost on monthly basis

Parameters	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Total
Patient A:
Total No. of doses	14	9	10	13	51	89	8	139	10	9	10	15	377
Doses, mg	70	45	53	65	255	445	40	691	50	45	50	75	1884
No. of vials	70	45	53	65	255	445	40	691	50	45	50	75	1884
Cost	259,000	166,500	196,100	240,500	943,500	1,646,500	148,000	2,556,700	159400	166,500	185,000	277,500	6,970,800
Patient B:
Total No. of doses	4	43	26	38	9	42	4	115	79	4	53	45	462
Doses, mg	24	297	222	209	45	289	23	677	518	26	265	315	2910
No. of vials	24	297	222	209	45	289	23	677	518	26	265	315	2910
Cost	88,800	1,098,900	821,400	773,300	166,500	1,069,300	85,100	2,504,900	1,916,600	96,200	980,500	1,165,500	10,767,000